Bleakley Financial Group’s HCA Healthcare HCA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-3,345
Closed -$1M 703
2024
Q4
$1M Sell
3,345
-1,671
-33% -$584K 0.03% 411
2024
Q3
$2.04M Sell
5,016
-37,015
-88% -$13.6M 0.06% 253
2024
Q2
$13.5M Sell
42,031
-68
-0.2% -$22.1K 0.39% 46
2024
Q1
$14M Buy
42,099
+8,562
+26% +$2.62M 0.41% 42
2023
Q4
$9.08M Buy
33,537
+284
+0.9% +$70.2K 0.29% 64
2023
Q3
$8.18M Buy
33,253
+7,401
+29% +$2.03M 0.29% 70
2023
Q2
$7.85M Buy
25,852
+21,593
+507% +$6M 0.24% 83
2023
Q1
$1.12M Buy
4,259
+59
+1% +$15K 0.04% 361
2022
Q4
$1.01M Buy
+4,200
New +$941K 0.04% 372

Other funds holding HCA

Bleakley Financial Group's HCA Position: Q1 2025 in Review

Bleakley Financial Group sold out of HCA Healthcare (HCA) in Q1 2025, closing a stake of 3,345 shares — an estimated $1M sold.

Bleakley Financial Group first reported a position in HCA in Q4 2022 and held it in 9 quarters. The position peaked at $14M in Q1 2024. 1,224 funds tracked by Wall St. Rank hold HCA as of Q1 2025.

  • Bleakley Financial Group reported no remaining HCA Healthcare position as of Q1 2025 after selling out during the quarter.
  • Bleakley Financial Group sold 3,345 HCA Healthcare shares in Q1 2025, an estimated $1M.
  • Bleakley Financial Group first reported a position in HCA Healthcare in Q4 2022 and held it in 9 quarters.
  • Bleakley Financial Group's HCA Healthcare position peaked at $14M in Q1 2024.
  • 1,224 funds tracked by Wall St. Rank held HCA Healthcare as of Q1 2025.

Based on Bleakley Financial Group's 13F filing for Q1 2025, filed 1 May 2025.